Sign In
Buy KHRNF
$0.00001
+0 (+0%)
At Close: Jul 31, 2026
Khiron to Participate in the Lytham Partners Winter 2021 Investor Conference
08:06am, Thursday, 09'th Dec 2021
TORONTO, Dec. 9, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operation
Khiron Life Sciences Corp (KHRNF) CEO Alvaro Torres on Q3 2021 Results - Earnings Call Transcript
09:02pm, Monday, 22'nd Nov 2021 Seeking AlphaKhiron Life Sciences Corp (KHRNF) CEO Alvaro Torres on Q3 2021 Results - Earnings Call Transcript
04:02pm, Monday, 22'nd Nov 2021
Khiron Life Sciences Corp (KHRNF) CEO Alvaro Torres on Q3 2021 Results - Earnings Call Transcript
Khiron Life Sciences Q3 Revenue Grows 83% YoY To $2.78M
01:05pm, Monday, 22'nd Nov 2021
Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMZC) announced its financial results on Monday for the quarter ended September 30, 2021 reporting revenues of CA$3.52 million ($2.7
Khiron Life Sciences is about to announce earnings here''s what Wall Street expects
02:01pm, Sunday, 21'st Nov 2021 Business Insider Markets
Khiron Life Sciences will release figures for Q3 on November 22. Analysts predict Khiron Life Sciences will report earnings per share of CAD 0.000. Go here to watch Khiron Life Sciences stock price in real-time on Markets
Khiron Life Sciences to Present at Upcoming November Investor Conferences
09:42am, Monday, 08'th Nov 2021
TORONTO, Nov. 8, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations
Khiron Life Sciences's Study: 80% Positively Respond To Cannabinoid Treatment For Chronic Pain And Other Conditions
04:28pm, Thursday, 07'th Oct 2021
A vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMZC) announced Wednesday results from its first research study including 1,453 patients fro
Khiron presents its first research study with 1,400 patients
06:00am, Thursday, 07'th Oct 2021
12-month observational study results presented at the International Pain Conference in Colombia on September 25 th, 2021 1st research study of its kind with a significant patient base for medical cann
Khiron reports medical cannabis prescription growth in South America and Europe
06:00am, Monday, 04'th Oct 2021
TORONTO, Oct. 4, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated international cannabis leader with c
Khiron's Announces Resignation of Chief Financial Officer Swapan Kakumanu of RTB LLP appointed as Interim CFO
05:40pm, Friday, 01'st Oct 2021
TORONTO, Oct. 1, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core op
Khiron Life Sciences: Doctor-Driven CBD Marketing Strategy
07:53am, Monday, 20'th Sep 2021
Khiron offers a unique opportunity in a sector with fast growth estimates.
Khiron Receives Approval To Renew Its Normal Course Issuer Bid
04:15pm, Monday, 13'th Sep 2021
TORONTO, Sept. 13, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core ope
Khiron's First Two CBD Products Now Available At Pharmacies In Peru
02:43pm, Tuesday, 31'st Aug 2021
Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX:KHRNF) announced on Tuesday that it has registered its first two finished medical cannabis products in Peru. The company is expanding its Latin American
Khiron Life Sciences Corp (KHRNF) CEO Alvaro Torres on Q2 2021 Results - Earnings Call Transcript
11:50pm, Monday, 23'rd Aug 2021
Khiron Life Sciences Corp (KHRNF) CEO Alvaro Torres on Q2 2021 Results - Earnings Call Transcript
